Name | (2R,3R,4S)-3-acetamido-4-(diaminomethylideneamino)-2-[(1R,2R)-2,3-dihydroxy-1-methoxypropyl]-3,4-dihydro-2H-pyran-6-carboxylic acid |
---|---|
Synonyms |
5-acetamido-4-guanidino-2,3,4,5-tetradeoxy-7-O-methyl-D-glycero-D-galacto-non-2-enopyranosoic acid
Laninamivir CS-8958 (6R)-5-Acetamido-2,6-anhydro-4-carbamimidamido-3,4,5-trideoxy-6-[(1R,2R)-2,3-dihydroxy-1-methoxypropyl]-L-threo-hex-2-enonic acid D-glycero-D-galacto-Non-2-enonic acid, 5-(acetylamino)-4-[(aminoiminomethyl)amino]-2,6-anhydro-3,4,5-trideoxy-7-O-methyl- |
Description | Laninamivir (R 125489) is a potent influenza neuraminidase (NA) inhibitor with IC50s of 0.90 nM, 1.83 nM and 3.12 nM for avian H12N5 NA (N5), pH1N1 N1 NA (p09N1) and A/RI/5+/1957 H2N2 N2 (p57N2), respectively[1]. |
---|---|
Related Catalog | |
Target |
IC50: 0.90 nM (N5), 1.83 nM (p09N1), 3.12 nM (p57N2)[1] |
In Vitro | Laninamivir inhibits efficiently common oseltamivir-resistant viruses, including those with the ubiquitous His274Tyr substitution[1]. Laninamivir is potent against p57N2, p09N1 and N5 with a similar binding mode to Zanamivir[1]. |
References |
Density | 1.6±0.1 g/cm3 |
---|---|
Molecular Formula | C13H22N4O7 |
Molecular Weight | 346.34 |
Exact Mass | 346.148834 |
PSA | 190.71000 |
LogP | -3.06 |
Index of Refraction | 1.634 |
Precursor 3 | |
---|---|
DownStream 0 |